Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NQMD-CS: A Prospective Interventional Study to Evaluate the Feasibility of a Blood-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population

NCT07834268 is registered in ClinicalTrials.gov with Fifth Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT07834268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07834268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NQMD-CS: A Prospective Interventional Study to Evaluate the Feasibility of a Blood-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population
Lead sponsor
Fifth Affiliated Hospital of Guangzhou Medical University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 2, 2025
Completion date
October 31, 2026
Enrollment
1,250 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, esophageal cancer, grastic cancer, liver cancer, lung cancer